Popular search terms:
Search Results
29 results found-
Here you will find the range of pharmaceutical products that we offer in the UK for immunodeficiency, haemophilia, and other rare and serious diseases.
https://www.cslbehring.co.uk/products/product-range -
CSL Behring is a specialty biotherapeutics company that is committed to treating people with rare and serious medical conditions.
https://www.cslbehring.co.uk/products -
CSL Behring is a global leader in the plasma protein biotherapies industry. We research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions.
https://www.cslbehring.co.uk/our-company -
CSL Behring is a global specialty biopharmaceutical company which aims to identify, develop and commercialise important, new, biotherapeutic products that help to prevent or treat serious medical conditions.
https://www.cslbehring.co.uk/research-and-development -
Product Name Beriplex P/N 250 IU powder and solvent for solution for injection Active Ingredient factor IX, factor II, factor VII, factor X, protein C, protein S Composition Beriplex is presented as powder and solvent for solution for injection containing human prothrombin complex Legal Category POM:
https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/may-2024-update/product-info---beriplex-v3.pdf -
Product Name Voncento 500 IU FVIII / 1200 IU VWF (5ml solvent) powder and solvent for solution for injection / infusion Active Ingredient Factor VIII, von willebrand factor Composition One vial of powder contains nominally:
https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/may-2024-update/product-info---voncento-v2.pdf -
Product Name Respreeza Active Ingredient human alpha1-proteinase inhibitor Composition 1,000 mg powder and solvent for solution for infusion.
https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/may-2024-update/product-info---respreeza-v4.pdf -
Product Name Idelvion 250 IU powder and solvent for solution for injection Active Ingredient Albutrepenonacog alfa (recombinant coagulation factor IX, albumin fusion protein) Composition One vial contains nominally 250 IU of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP), (INN = albutrepenonacog alfa).
https://www.cslbehring.co.uk/-/media/cslb-uk/product-information/february-2024/idelvion-0224.pdf -
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
https://www.cslbehring.co.uk/products/regulatory-compliance -
CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide.
https://www.cslbehring.co.uk/terms-of-use